Results
11
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
11 companies
Maxigen Biotech
Market Cap: NT$3.5b
Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.
1783
NT$43.80
7D
0.6%
1Y
-5.9%
TCM Biotech International
Market Cap: NT$5.9b
A biotech company, engages in the research and development of drugs for liver diseases.
4169
NT$99.90
7D
-0.1%
1Y
63.2%
Savior Lifetec
Market Cap: NT$5.8b
A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.
4167
NT$18.30
7D
-2.7%
1Y
-20.3%
Panion & Bf Biotech
Market Cap: NT$5.9b
A biotechnology pharmaceutical company, provides western medicines, cosmetics, and health care products in Taiwan, the United States, China, Hong Kong, and internationally.
1760
NT$69.30
7D
-0.4%
1Y
-25.4%
Syngen BiotechLtd
Market Cap: NT$3.3b
Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally.
8279
NT$121.00
7D
-2.0%
1Y
-11.0%
Sunmax Biotechnology
Market Cap: NT$22.2b
A biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China.
4728
NT$408.00
7D
-1.0%
1Y
44.7%
Nang Kuang Pharmaceutical
Market Cap: NT$3.8b
Manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally.
1752
NT$38.00
7D
8.0%
1Y
-16.9%
PharmaEngine
Market Cap: NT$9.5b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$65.90
7D
-4.2%
1Y
-23.9%
Ever Supreme Bio Technology
Market Cap: NT$13.7b
Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.
6712
NT$156.00
7D
1.6%
1Y
-6.5%
TTY Biopharm
Market Cap: NT$18.9b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$76.20
7D
-0.5%
1Y
1.6%
SCI Pharmtech
Market Cap: NT$7.1b
Together with its subsidiary, engages in the research and development, manufacture, and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals in Italy, the United States, Japan, Germany, Taiwan, Switzerland, China, and internationally.
4119
NT$59.10
7D
-0.7%
1Y
-33.2%